Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novogen Ltd (NASDAQ:NVGN)

2.24
Delayed Data
As of 1:51pm ET
 -0.099 / -4.23%
Today’s Change
1.79
Today|||52-Week Range
7.66
+7.22%
Year-to-Date
No recent news for Novogen Ltd.

Today’s Trading

Previous close2.34
Today’s open2.37
Day’s range2.17 - 2.38
Volume25,458
Average volume (3 months)40,931
Market cap$40.2M
Dividend yield--
Data as of 1:51pm ET, 04/29/2016

Growth & Valuation

Earnings growth (last year)+42.50%
Earnings growth (this year)+12.09%
Earnings growth (next 5 years)+4.00%
Revenue growth (last year)--
P/E ratio--
Price/Sales--
Price/Book1.20

Competitors

 Today’s
change
Today’s
% change
NTECIntec Pharma Ltd+0.09+2.71%
ACURAcura Pharmaceutical...+0.04+1.08%
PTNPalatin Technologies...-0.06-9.98%
VICLVical Inc-0.01-2.91%
Data as of 2:07pm ET, 04/29/2016

Financials

Next reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$0.00
Annual profit (last year)-$5.9M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
James Garner
Chief Financial Officer
Cristyn Humphreys
Corporate headquarters
Hornsby, New South Wales (nsw)

Forecasts

Partner Offers

Search for Jobs